Inventor · disambiguated record
Bal Ram Singh
Also filed as: SINGH BAL RAM
16 granted patents·13 pending applications·75 citations·filing 2000–2025
92Inventor score
Files withPRIME BIO INC10SINGH BAL RAM8UNIV MASSACHUSETTS5B B SCIENT L L C2INST OF ADVANCED SCIENCES2
Top patents by PatentIndex Score
29 records- 0191US8586081B2Detoxified recombinant botulinum neurotoxinSINGH BAL RAM·Filed 2008·Granted Nov 19, 2013·13 cites·11 claims
- 0286US7981432B2Proteins within the type E botulinum neurotoxin complexUNIV MASSACHUSETTS·Filed 2008·Granted Jul 19, 2011·3 cites·6 claims
- 0385US11957740B2Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potencyPRIME BIO INC·Filed 2021·Granted Apr 16, 2024·1 cites·8 claims
- 0485US6699966B1Proteins within the type E botulinum neurotoxin complexUNIV MASSACHUSETTS·Filed 2000·Granted Mar 2, 2004·20 cites·26 claims
- 0583US6994859B1Biologically active, hemagglutinin from type A Clostridium botulinum and methods of useUNIV MASSACHUSETTS·Filed 2000·Granted Feb 7, 2006·16 cites·6 claims
- 0682US9139624B2Biologically active hemagglutinin from type a Clostridium botulinum and methods of useSINGH BAL RAM·Filed 2009·Granted Sep 22, 2015·5 cites·16 claims
- 0781US11040090B2Botulinum neurotoxin compositionsSINGH BAL RAM·Filed 2016·Granted Jun 22, 2021·2 cites·22 claims
- 0877US7531183B2Biologically active hemagglutinin from type A Clostridium botulinum and methods of useUNIV MASSACHUSETTS·Filed 2005·Granted May 12, 2009·2 cites·8 claims
- 0975US12233119B2Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteinsPRIME BIO INC·Filed 2023·Granted Feb 25, 2025·0 cites·6 claims
- 1075US7431935B2Proteins within the type E botulinum neurotoxin complexUNIV MASSACHUSETTS·Filed 2004·Granted Oct 7, 2008·4 cites·15 claims
- 1173US12285469B2Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potencyINST OF ADVANCED SCIENCES INC·Filed 2024·Granted Apr 29, 2025·0 cites·10 claims
- 1273US11771752B2Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteinsPRIME BIO INC·Filed 2016·Granted Oct 3, 2023·1 cites·13 claims
- 1372US7744904B1Stabilization of Clostridium botulinum neurotoxin complexB B SCIENT L L C·Filed 2006·Granted Jun 29, 2010·5 cites·13 claims
- 1470US12194090B2Tetanus vaccine platform for embedding COVID-19 vaccinePRIME BIO INC·Filed 2022·Granted Jan 14, 2025·0 cites·14 claims
- 1568US11389497B2Pharmaceutical composition for treating cancerINST OF ADVANCE SCIENCES INC·Filed 2020·Granted Jul 19, 2022·1 cites·15 claims
- 1668US8748106B2Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin IISINGH BAL RAM·Filed 2006·Granted Jun 10, 2014·2 cites·12 claims
- 1767US2025122243A1Protein based vaccine and production method thereof for sars cov-2PRIME BIO INC·Filed 2023·Application pending·0 cites
- 1863US2024424080A1Multi-Epitope Vaccine PlatformINST OF ADVANCED SCIENCES·Filed 2023·Application pending·0 cites
- 1963US2025017855A1Pharmaceutical Preparation for Topical Delivery of Botulinum ToxinINST OF ADVANCED SCIENCES·Filed 2023·Application pending·0 cites
- 2057US2022390461A1Method for the detection of clostridium neurotoxins using a novel substratePRIME BIO INC·Filed 2021·Application pending·0 cites
- 2155US2025144201A1Tetanus vaccine platform for embedding covid-19 vaccinePRIME BIO INC·Filed 2025·Application pending·0 cites
- 2255US2015010535A1Methods of Identifying a Compound that Increases or Decreases the Interaction of Hn-33 with Synaptotagmin IISINGH BAL RAM·Filed 2014·Application pending·0 cites
- 2353US2012171247A1Novel proteins within the type e botulinum neurotoxin complexSINGH BAL RAM·Filed 2011·Application pending·0 cites
- 2447US2021346292A1Pharmaceutical preparation for increasing stability and bioavailability of Botulinum toxin A and its complexSINGH BAL RAM·Filed 2020·Application pending·0 cites
- 2546US2021121542A1Composition for delivery of protein therapeutics through oral, sublingual and buccal routePRIME BIO INC·Filed 2020·Application pending·0 cites
- 2644US2022226282A1Natural Product Antidotes against Botulinum NeurotoxinsPRIME BIO INC·Filed 2021·Application pending·0 cites
- 2741US2016051644A1Botulinum Chimera Compositions for Axonal Regenerative Therapy During Spinal Cord InjurySINGH BAL RAM·Filed 2014·Application pending·0 cites
- 2834US2018147223A1Botulinum neurotoxin inhibitorsPRIME BIO INC·Filed 2016·Application pending·0 cites
- 2931US2010222254A1Stabilization of clostridium botulinum neurotoxin complexB B SCIENT L L C·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bal Ram Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →